Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hourmant

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
Transplantation Proceedings|October 1, 1988
Use of a monoclonal antibody directed against interleukin 2 receptor in recipients of kidney allograftsJ P Soulillou, B Le Mauff, D Cantarovich, et al.
Journal of Clinical Laboratory Analysis|July 16, 2008
Comparison between a liquid chromatography-tandem mass spectrometry assay and a fluorescent polarization immunoassay to measure whole blood everolimus concentration in heart and renal transplantationsEric Dailly, G Deslandes, M Hourmant, et al.
Bone Marrow Transplantation|October 1, 1994
Autologous bone marrow transplantation for cyclosporin-related lymphoma in a renal transplant patientB Mahe, P Moreau, S Le Tortorec, et al.
Presse Medicale (Paris, France : 1983)|July 9, 1983
[Test of differential anti-T and anti-B lymphocyte compatibility in renal transplantation. A partial solution to the problem of hyperimmune patients]J D Bignon, J P Soulillou, M Hourmant, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1997
Frequency of mucosal HPV DNA detection (types 6/11, 16/18, 31/35/51) in skin lesions of renal transplant patientsE Mansat-Krzyzanowska, J Dantal, M Hourmant, et al.
Nephrologie & Therapeutique|October 15, 2013
[Access to the waiting list and renal transplantation]M Hourmant, F de Cornelissen, P Brunet, et al.
Nephrologie & Therapeutique|November 6, 2012
[Access to kidney transplantation]M Hourmant, M Kessler, J-B Beuscart, et al.
Transplantation Proceedings|June 1, 1992
Importance of cyclosporine dosage and blood levels in simultaneous pancreas and kidney transplant successD Cantarovich, J Dantal, M Hourmant, et al.
Transplantation Proceedings|April 1, 1994
Five-year experience with segmental duct-occluded pancreatic graftsD Cantarovich, J Paineau, G Karam, et al.
Transplantation Proceedings|February 1, 1993
HLA-DR matching assessed by DNA analysis in kidney transplantation--a one-center studyJ D Bignon, S Nataf, M Hourmant, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
Transplantation Proceedings|October 1, 1988
Use of a monoclonal antibody directed against interleukin 2 receptor in recipients of kidney allograftsJ P Soulillou, B Le Mauff, D Cantarovich, et al.
Journal of Clinical Laboratory Analysis|July 16, 2008
Comparison between a liquid chromatography-tandem mass spectrometry assay and a fluorescent polarization immunoassay to measure whole blood everolimus concentration in heart and renal transplantationsEric Dailly, G Deslandes, M Hourmant, et al.
Bone Marrow Transplantation|October 1, 1994
Autologous bone marrow transplantation for cyclosporin-related lymphoma in a renal transplant patientB Mahe, P Moreau, S Le Tortorec, et al.
Presse Medicale (Paris, France : 1983)|July 9, 1983
[Test of differential anti-T and anti-B lymphocyte compatibility in renal transplantation. A partial solution to the problem of hyperimmune patients]J D Bignon, J P Soulillou, M Hourmant, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1997
Frequency of mucosal HPV DNA detection (types 6/11, 16/18, 31/35/51) in skin lesions of renal transplant patientsE Mansat-Krzyzanowska, J Dantal, M Hourmant, et al.
Nephrologie & Therapeutique|October 15, 2013
[Access to the waiting list and renal transplantation]M Hourmant, F de Cornelissen, P Brunet, et al.
Nephrologie & Therapeutique|November 6, 2012
[Access to kidney transplantation]M Hourmant, M Kessler, J-B Beuscart, et al.
Transplantation Proceedings|June 1, 1992
Importance of cyclosporine dosage and blood levels in simultaneous pancreas and kidney transplant successD Cantarovich, J Dantal, M Hourmant, et al.
Transplantation Proceedings|April 1, 1994
Five-year experience with segmental duct-occluded pancreatic graftsD Cantarovich, J Paineau, G Karam, et al.
Transplantation Proceedings|February 1, 1993
HLA-DR matching assessed by DNA analysis in kidney transplantation--a one-center studyJ D Bignon, S Nataf, M Hourmant, et al.
Pageof 10